Companies: 10,795·Total market cap: $144.5T
Pluri Inc.

Pluri Inc.

PLURNASDAQHealthcare● Active
$2.31
$-0.05(-2.12%)
Market Cap$20770748
P/E Ratio
52W High$5.96
52W Low$2.22

Pluri Inc. (PLUR) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · PLUR · as of Sep 30, 2025

Ownership Breakdown

Institutions 0.58%
Insiders 48.38%
Public 51.04%

19

Institutional Holders

▼ 1 vs Q2

$234,927

Total Inst. Value

▼ $145,841 vs Q2

8.99M

Shares Outstanding

freeFloat 51.62%

52,329

13F Shares Held

▼ 24,518 vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

PLUR largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

RENAISSANCE TECHNOLOGIES LLC

biological products, (no diagnostic substances)

33.9K37.71%

37.71%

$151.96MNov 13, 2025 6.5K

VALUES FIRST ADVISORS, INC.

biological products, (no diagnostic substances)

11.9K13.24%

13.24%

$53.33MOct 21, 2025 217

MORGAN STANLEY

biological products, (no diagnostic substances)

3.2K3.53%

3.53%

$14.23MMay 27, 2026 94

EVERSOURCE WEALTH ADVISORS, LLC

biological products, (no diagnostic substances)

2.0K2.22%

2.22%

$8.96MNov 10, 2025— held

biological products, (no diagnostic substances)

3500.39%

0.39%

$1.57MMay 28, 2026NEW

WELLS FARGO & COMPANY/MN

biological products, (no diagnostic substances)

1850.21%

0.21%

$829,000Nov 13, 2025— held

ZURCHER KANTONALBANK (ZURICH CANTONALBANK)

biological products, (no diagnostic substances)

1360.15%

0.15%

$651,000Nov 14, 2025— held

ROYAL BANK OF CANADA

biological products, (no diagnostic substances)

1250.14%

0.14%

$1.00MNov 14, 2025— held

JPMORGAN CHASE & CO

biological products, (no diagnostic substances)

1250.14%

0.14%

$600,000Nov 26, 2025— held

TD WATERHOUSE CANADA INC.

biological products, (no diagnostic substances)

930.10%

0.10%

$419,000Nov 3, 2025— held

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBearish — more selling than buying

2

Increased

+6.6K shares

3

New Positions

first time holders

3

Decreased

−475 shares

4

Sold Out

fully exited

Net shares change (top 50)

+6.1K

+6.6K / −475

Net new holders

-2

3 new / 4 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

PLUR insider trading · insider activity

Source: SEC Form 4

3

Buy transactions

0

Sell transactions

0.00

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

Manieu Alexandre Weinstein

Apr 21, 2026Award312,500$2.00$625.0K1.25MForm 4 ↗

Manieu Alexandre Weinstein

Apr 21, 2026Award312,500$4.25$1.33M1.25MForm 4 ↗

Manieu Alexandre Weinstein

Mar 31, 2026Award312,500$2.00$625.0K937.5KForm 4 ↗

Manieu Alexandre Weinstein

Mar 31, 2026Award312,500$4.25$1.33M937.5KForm 4 ↗

Manieu Alexandre Weinstein

Dec 8, 2025Award625,000$4.25$2.66M625.0KForm 4 ↗

Manieu Alexandre Weinstein

Dec 8, 2025Award625,000$2.00$1.25M625.0KForm 4 ↗

Manieu Alexandre Weinstein

Dec 4, 2025Award51910.8KForm 4 ↗

Ajchenbaum Eitan

director

Dec 4, 2025Award66812.4KForm 4 ↗

YANAY YAKY

Chief Executive Officer

Dec 4, 2025Award6,588497.8KForm 4 ↗

Levi Rami Avraham

director

Dec 4, 2025Award65319.0KForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Pluri Inc. (PLUR) is primarily owned by institutional investors, who hold approximately 0.6% of total shares outstanding. Company insiders own approximately 48.38%, while retail and public investors account for the remaining 51.04%.

The largest institutional shareholder of Pluri Inc. is RENAISSANCE TECHNOLOGIES LLC, holding approximately 33,925 shares — equal to 37.71% of outstanding shares — as of September 30, 2025.

A total of 19 institutional investors currently hold PLUR stock, with a combined institutional value of approximately $234,927 as of the most recent 13F filing period.

Frequently asked questions

PLUR ownership

Pluri Inc. (PLUR) is primarily owned by institutional investors, who hold approximately 0.6% of shares. The largest shareholder is RENAISSANCE TECHNOLOGIES LLC with a 37.71% stake. Company insiders hold 48.38%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns PLUR stockPLUR ownership structureSEC Form 13F institutional holdingsPLUR float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025